Form 4: Intuitive Surgical Officer Exercises Options, Sells Shares

Intuitive Surgical's EVP & Chief Medical Officer, Myriam Curet, exercised stock options and sold an equal number of shares under a pre-arranged 10b5-1 trading plan.

Summary

• Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical Inc. (ISRG), executed transactions on December 1, 2025.
• Curet exercised 125 non-qualified stock options at an exercise price of $208.9 per share.
• Concurrently, Curet sold 125 shares of common stock at a price of $568.99 per share.
• These transactions were conducted in accordance with a Rule 10b5-1 trading plan, which is set to expire on July 29, 2026.
• Following these transactions, Curet directly owns 0 shares of common stock and indirectly owns 353 shares through a trust.
• Curet retains beneficial ownership of 376 non-qualified stock options, which have an exercise price of $208.9 and an expiration date of August 28, 2029.

Sentiment

Score: 5

Explanation: The filing reports a routine, pre-planned insider transaction under a 10b5-1 plan, which is neutral in terms of company-specific sentiment. It reflects an executive managing their compensation rather than a signal about company performance.

Positives

• The reporting person realized a profit from the exercise of stock options and subsequent sale of shares, indicating a positive return on their equity compensation.
• The transactions were executed under a Rule 10b5-1 trading plan, which demonstrates pre-planned and systematic insider trading, reducing concerns about opportunistic timing.

Negatives

• The reporting person's direct beneficial ownership of common stock decreased to zero following the sale of shares.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing details a routine insider transaction for an executive at a medical device company. Such transactions are common for executives managing their equity compensation and do not typically reflect broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The transaction represents a routine sale of shares by an executive, which is unlikely to have a significant impact on the company's stock price or long-term value. It reflects an executive diversifying their personal holdings.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The Rule 10b5-1 trading plan will remain active until its expiration on July 29, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned insider transaction by an executive exercising stock options and selling shares under a Rule 10b5-1 plan. Such transactions are common for executive compensation management and do not typically provide new fundamental information about the company's operational performance, strategic direction, or future prospects. Therefore, it does not warrant a change in an investment recommendation based solely on this disclosure.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Transaction, Stock Option Exercise, Share Sale, 10b5-1 Plan, Myriam Curet, Executive Compensation